Summary

• UHCW has launched a digital medicines management system linking Omnicell automation with Oracle Health’s EPR.
• The system is designed to give clinicians real-time visibility of medicine availability and reduce administration.
• NHS digital transformation depends on connecting operational systems, not just deploying headline platforms.

University Hospitals Coventry and Warwickshire NHS Trust has launched an interoperable digital medicines management system that connects Omnicell automation with the trust’s Oracle Health electronic patient record.

The system went live on 15 June 2026 and is designed to give clinicians real-time visibility of medicine availability across the hospital. UHCW says the deployment will save nurses time and support safer care, with the integration also expected to reduce medicines waste and streamline medicines management.

The deployment focuses on workflow rather than technology theatre. Medicines management touches nursing, pharmacy, prescribing, ward operations, procurement, safety governance, and patient experience. When systems are disconnected, staff can lose time searching for medicines, reconciling information, and working around gaps between stock data and clinical records.

By linking automated dispensing cabinets and robotic dispensing to the electronic patient record, UHCW is trying to turn medicines availability into live operational data. That can change how medication rounds are planned, how pharmacy teams manage supply, and how delays are reduced at the point of care. The value is not automation alone, but the connection between medicines infrastructure and clinical workflow.

The project also shows why NHS digitisation cannot be judged only by whether an organisation has an EPR. Electronic records are necessary, but benefits depend on integration with surrounding systems: pharmacy, diagnostics, scheduling, finance, bed management, and reporting. A hospital can have a modern record system and still leave frontline staff dealing with fragmented operational tools.

Nurses will judge the system through practical use. If staff can see where medicines are, how to obtain them, and whether the supply process is safe and efficient, digital technology becomes part of daily clinical productivity. If the system adds clicks without improving availability, adoption will be weaker.

UHCW’s claim that the system is the first of its kind in England should be handled carefully until comparable deployments are assessed, but the integration model is clearly important. NHS organisations are under pressure to reduce waste, improve patient safety, and free staff from avoidable administration. Medicines management is a high volume area where small process improvements can accumulate quickly.

The supplier ecosystem matters too. Omnicell provides the automation layer, Oracle Health provides the EPR, and UHCW has to make the system work inside a complex clinical environment. Interoperability is often promised in health technology, but real value depends on interfaces, data quality, staff training, support, and governance.

The deployment’s wider significance will become clearer if UHCW can evidence measurable reductions in delay, waste, and staff time. Health technology adoption is strongest when it can show operational benefits in the language hospitals already use: safety, flow, capacity, and clinical time.